Healthpoint Capital LLC New York City, NY - 10022

Healthpoint Capital LLC is categorized under Medical Research in New York City, NY and active since 2002.

Healthpoint Capital LLC was established in 2002, and today employs 1 to 4, earning Unknown per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 5239100 by the NAICS.

If you are seeking more information, feel free to contact Mortimer Berkowitz III, President at the company’s headquarters by writing to 505 Park Avenue Floor 12, New York City, New York NY 10022 or by phoning (212) 935-7780. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Healthpoint Capital LLC
Contact Person: Mortimer Berkowitz III, President
Address: 505 Park Avenue Floor 12, New York City, New York 10022
Phone Number: (212) 935-7780
Website Address: healthpointcapital.com
Annual Revenue (USD): Unknown
Founded: 2002
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Medical Research
SIC Code: 8733
NAICS Code: 5239100
Share This Business:

Healthpoint Capital LLC was started in 2002 to provide professional Medical Research under the SIC code 8733 and NAICS code 5239100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Mortimer Berkowitz III, President for inquiries that concern Healthpoint Capital LLC by calling the company number (212) 935-7780, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Healthpoint Capital LLC can be found at the coordinates 40.758403,-73.967199 as well as the street address 505 Park Avenue Floor 12 in New York City, New York 10022.

For its online presence, you may visit Healthpoint Capital LLC’s website at healthpointcapital.com and engage with its social media outlets through on Twitter and on Facebook.